These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 18303490

  • 21. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 22. "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting.
    Hajak G, Bandelow B, Zulley J, Pittrow D.
    Ann Clin Psychiatry; 2002 Mar; 14(1):1-7. PubMed ID: 12046635
    [Abstract] [Full Text] [Related]

  • 23. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK, Thacker S, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [Abstract] [Full Text] [Related]

  • 24. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.
    Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW.
    Arch Intern Med; 2004 Sep 27; 164(17):1888-96. PubMed ID: 15451764
    [Abstract] [Full Text] [Related]

  • 25. Sensitivity of cyclic alternating pattern to prolonged pharmacotherapy: a 5-week study evaluating zolpidem in insomniac patients.
    Terzano MG, Parrino L, Boselli M, Spaggiari MC, Di Giovanni G, Smerieri A.
    Clin Neuropharmacol; 1997 Oct 27; 20(5):447-54. PubMed ID: 9331522
    [Abstract] [Full Text] [Related]

  • 26. Effect of zolpidem on sleep in healthy subjects: a placebo-controlled trial with polysomnographic recordings.
    Blois R, Gaillard JM, Attali P, Coquelin JP.
    Clin Ther; 1993 Oct 27; 15(5):797-809. PubMed ID: 8269446
    [Abstract] [Full Text] [Related]

  • 27. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
    Voshaar RC, van Balkom AJ, Zitman FG.
    Eur Neuropsychopharmacol; 2004 Aug 27; 14(4):301-6. PubMed ID: 15163440
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB, Lankford DA, Seiden DJ, Landin R, Farber R, Walsh JK.
    J Clin Sleep Med; 2006 Jul 15; 2(3):309-15. PubMed ID: 17561543
    [Abstract] [Full Text] [Related]

  • 29. Dose response effects of zolpidem in normal geriatric subjects.
    Scharf MB, Mayleben DW, Kaffeman M, Krall R, Ochs R.
    J Clin Psychiatry; 1991 Feb 15; 52(2):77-83. PubMed ID: 1993640
    [Abstract] [Full Text] [Related]

  • 30. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN, Joffe H, Rubens R, Caron J, Roth T, Cohen L.
    Obstet Gynecol; 2006 Dec 15; 108(6):1402-10. PubMed ID: 17138773
    [Abstract] [Full Text] [Related]

  • 31. Effect of hypnotic drugs on sleep architecture.
    Terzano MG, Parrino L.
    Pol J Pharmacol; 1994 Dec 15; 46(5):487-90. PubMed ID: 7894540
    [Abstract] [Full Text] [Related]

  • 32. [The effectiveness of treatment with trazodone in patients with primary insomnia without and with prior history of hypnotics use].
    Wichniak A, Wierzbicka A, Sobańska A, Szatkowska E, Czasak K, Musińska I, Jernajczyk W.
    Pol Merkur Lekarski; 2007 Jul 15; 23(133):41-6. PubMed ID: 18051828
    [Abstract] [Full Text] [Related]

  • 33. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J.
    Clin Ther; 2006 Apr 15; 28(4):491-516. PubMed ID: 16750462
    [Abstract] [Full Text] [Related]

  • 34. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia.
    Staner C, Joly F, Jacquot N, Vlasova ID, Nehlin M, Lundqvist T, Edenius C, Staner L.
    Curr Med Res Opin; 2010 Jun 15; 26(6):1423-31. PubMed ID: 20397964
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK, Moscovitch A, Burke J, Farber R, Roth T.
    Sleep Med; 2007 Nov 15; 8(7-8):753-9. PubMed ID: 17825616
    [Abstract] [Full Text] [Related]

  • 36. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
    Gann H, Feige B, Cloot O, Van Wasen H, Zinzgraf D, Hohagen F, Riemann D.
    Pharmacopsychiatry; 2004 Sep 15; 37(5):228-35. PubMed ID: 15359376
    [Abstract] [Full Text] [Related]

  • 37. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
    Herrmann WM, Kubicki ST, Boden S, Eich FX, Attali P, Coquelin JP.
    J Int Med Res; 1993 Sep 15; 21(6):306-22. PubMed ID: 8143886
    [Abstract] [Full Text] [Related]

  • 38. Rebound insomnia: duration of use and individual differences.
    Merlotti L, Roehrs T, Zorick F, Roth T.
    J Clin Psychopharmacol; 1991 Dec 15; 11(6):368-73. PubMed ID: 1770156
    [Abstract] [Full Text] [Related]

  • 39. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ, Wang-Weigand S, Zhang J.
    Am J Geriatr Pharmacother; 2007 Sep 15; 5(3):177-84. PubMed ID: 17996657
    [Abstract] [Full Text] [Related]

  • 40. Effects of zolpidem on the architecture and cyclical structure of sleep in poor sleepers.
    Besset A, Tafti M, Villemin E, Borderies P, Billiard M.
    Drugs Exp Clin Res; 1995 Sep 15; 21(4):161-9. PubMed ID: 8529530
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.